Small, George W <br/><br/>
Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Dec 2003 
 - 861-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.103.055806  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracyclines--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Breast Neoplasms--enzymology<br/>Cell Line, Tumor<br/>Clone Cells<br/>Dual Specificity Phosphatase 1<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Epithelial Cells--drug effects<br/>Female<br/>Fluorescent Antibody Technique<br/>Gene Silencing--drug effects<br/>Humans<br/>Luciferases--biosynthesis<br/>Mice<br/>Mice, Knockout<br/>Mitogen-Activated Protein Kinase 3<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Phosphorylation<br/>Promoter Regions, Genetic--drug effects<br/>Protein Phosphatase 1<br/>Protein Tyrosine Phosphatases--antagonists & inhibitors<br/>RNA, Messenger--biosynthesis<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction--drug effects<br/>Transcription, Genetic